Stryker Beheer
Beheer criteriumcontroles 3/4
De CEO Stryker is Kevin Lobo, benoemd in Oct2012, heeft een ambtstermijn van 12.08 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 20.77M, bestaande uit 6.7% salaris en 93.3% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.026% van de aandelen van het bedrijf, ter waarde $ 37.21M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.2 jaar en 6.5 jaar.
Belangrijke informatie
Kevin Lobo
Algemeen directeur
US$20.8m
Totale compensatie
| Percentage CEO-salaris | 6.7% |
| Dienstverband CEO | 12.1yrs |
| Eigendom CEO | 0.03% |
| Management gemiddelde ambtstermijn | 6.2yrs |
| Gemiddelde ambtstermijn bestuur | 6.5yrs |
Recente managementupdates
Recent updates
Stryker's Growth Via Continuous Acquisitions Led To Declining ROIC
Oct 16We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Oct 10
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Sep 29Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Sep 18We Think Stryker (NYSE:SYK) Can Stay On Top Of Its Debt
Sep 01Stryker Corporation's (NYSE:SYK) Business Is Trailing The Market But Its Shares Aren't
Aug 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Aug 10Stryker: Wait For A Better Entry Point Post-Q2 Results
Aug 06Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?
Jul 11A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Jun 30Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
Jun 19The Returns At Stryker (NYSE:SYK) Aren't Growing
Jun 16Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Jun 05Stryker: Margin Gains Should Drive Upside
May 31Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?
May 25Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings
May 14Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today
Jan 02Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 22Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 08Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
Aug 22Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Jul 18Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price
Jul 06Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$4b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$3b |
| Dec 31 2023 | US$21m | US$1m | US$3b |
| Sep 30 2023 | n/a | n/a | US$3b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$3b |
| Dec 31 2022 | US$19m | US$1m | US$2b |
| Sep 30 2022 | n/a | n/a | US$2b |
| Jun 30 2022 | n/a | n/a | US$2b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$16m | US$1m | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$13m | US$1m | US$2b |
| Sep 30 2020 | n/a | n/a | US$2b |
| Jun 30 2020 | n/a | n/a | US$2b |
| Mar 31 2020 | n/a | n/a | US$2b |
| Dec 31 2019 | US$15m | US$1m | US$2b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$4b |
| Mar 31 2019 | n/a | n/a | US$4b |
| Dec 31 2018 | US$14m | US$1m | US$4b |
| Sep 30 2018 | n/a | n/a | US$1b |
| Jun 30 2018 | n/a | n/a | US$1b |
| Mar 31 2018 | n/a | n/a | US$1b |
| Dec 31 2017 | US$14m | US$1m | US$1b |
Compensatie versus markt: De totale vergoeding ($USD 20.77M ) Kevin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 12.86M ).
Compensatie versus inkomsten: De vergoeding van Kevin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Kevin Lobo (59 yo)
12.1yrs
Tenure
US$20,767,847
Compensatie
Mr. Kevin A. Lobo has been the Chief Executive Officer of Stryker Corporation since October 1, 2012 and serves as its President since October 01, 2021. He serves as Chairman of the Board at The Advanced Me...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 12.1yrs | US$20.77m | 0.026% $ 37.2m | |
| VP & CFO | 8.6yrs | US$6.84m | 0.0011% $ 1.6m | |
| Group President of Global Quality & Operations | 6.6yrs | US$4.47m | 0.0024% $ 3.4m | |
| Group President of MedSurg & Neurotechnology | 6.3yrs | US$6.49m | 0.015% $ 21.5m | |
| Group President of Orthopaedics & Spine | 6.3yrs | US$6.49m | 0.014% $ 19.6m | |
| VP & Chief Accounting Officer | 3.3yrs | geen gegevens | 0.00078% $ 1.1m | |
| CTO and VP of Global R&D - Joint Replacement | no data | geen gegevens | geen gegevens | |
| VP, Chief Information Officer & Chief Information Security Officer | 6.2yrs | geen gegevens | geen gegevens | |
| Vice President of Finance & Investor Relations | 2.3yrs | geen gegevens | geen gegevens | |
| VP & Chief Legal Officer | 5.6yrs | US$2.24m | 0.0024% $ 3.5m | |
| VP & Chief Compliance Officer | no data | geen gegevens | geen gegevens | |
| VP of Communications | 5.9yrs | geen gegevens | 0.0082% $ 11.6m |
6.2yrs
Gemiddelde duur
57yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van SYK is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.2 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman | 12.1yrs | US$20.77m | 0.026% $ 37.2m | |
| Independent Director | 4.5yrs | US$319.25k | 0.00085% $ 1.2m | |
| Director Emeritus | 6.5yrs | US$38.86k | geen gegevens | |
| Chairman Emeritus | no data | US$286.99k | 5.26% $ 7.4b | |
| Independent Director | 40.8yrs | US$319.25k | 4.83% $ 6.8b | |
| Independent Director | 7.3yrs | US$334.25k | 0.0015% $ 2.2m | |
| Independent Director | 13.8yrs | US$334.25k | 0.0039% $ 5.5m | |
| Lead Independent Director | 6.5yrs | US$359.25k | 0.00022% $ 310.2k | |
| Independent Director | 6.5yrs | US$319.25k | 0.0014% $ 1.9m | |
| Independent Director | 3.9yrs | US$319.25k | 0.00067% $ 944.7k | |
| Independent Director | 11yrs | US$339.25k | 0.0015% $ 2.1m | |
| Independent Director | less than a year | geen gegevens | 0.000010% $ 14.1k |
6.5yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van SYK wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).